Fig. 2 | Scientific Reports

Fig. 2

From: MYH9 promotes malignant progression of glioma cells through regulating β-catenin stability via epithelial-mesenchymal transition signaling pathway

Fig. 2The alternative text for this image may have been generated using AI.

MYH9 was highly expressed in human gliomas. (A) MYH9 mRNA expression in glioma tissues and para-tumor tissues among the glioma patients obtained from the TCGA database. (B) MYH9 mRNA level in gliomas from the CGGA database. (C) MYH9 had higher expression in IDH-wildtype gliomas. (D) The expression of MYH9 in tumor and adjacent samples were monitored by immunohistochemistry. (E,F) MYH9 mRNA and protein levels in glioma cell lines. (G–I) β-catenin and N-cadherin expression was positively correlated with MYH9 expression, whereas E-cadherin expression was negatively correlated with MYH9 expression from the GEPIA database. *P < 0.05, **P < 0.01, ***P < 0.001.

Back to article page